Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 15.8 | 13.0 | 20.4 | 6.1 | 66.2 | 20.6 | 3.0 | 7.8 |
| Revenue growth | 21.2% | -36.2% | 232.1% | -90.7% | 221.5% | 585.5% | -61.6% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 15.8 | 13.0 | 20.4 | 6.1 | 66.2 | 20.6 | 3.0 | 7.8 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 17.0 | 15.9 | 17.9 | 5.5 | 25.1 | 7.1 | 0.8 | 1.8 |
| General and administrative | 20.6 | 7.6 | 3.4 | 2.6 | 5.8 | 3.2 | 0.7 | 2.1 |
| EBIT | -22.1 | -10.5 | -1.0 | -1.9 | 33.1 | 10.3 | 1.5 | 3.9 |
| EBIT margin | -140.4% | -80.7% | -4.9% | -31.2% | 50.0% | 50.0% | 50.0% | 50.0% |
| Pre-tax income | -21.8 | -10.9 | -1.5 | -1.9 | 32.9 | 10.5 | 1.6 | 3.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 |
| Tax rate | 0.0% | | | | 0.1% | | 0.0% | 0.0% |
| Net income | -21.8 | -10.9 | -1.6 | -1.9 | 32.8 | 10.5 | 1.6 | 4.1 |
| Net margin | -138.3% | -83.9% | -7.7% | -31.0% | 49.6% | 51.3% | 52.6% | 52.6% |
| |
| Diluted EPS | ($2.16) | ($3.53) | ($0.77) | ($0.94) | $2.40 | $1.04 | $0.20 | $0.52 |
| Shares outstanding (diluted) | 10.1 | 3.1 | 2.0 | 2.0 | 13.7 | 10.2 | 7.8 | 7.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|